Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Kandiel, Ahmed; G Fraser, A; I Korelitz, B; Brensinger, C; D Lewis, J

doi:10.1136/gut.2004.049460

Public

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

Published in Gut • Jul 11, 2005

Authors:

Ahmed Kandiel

A G Fraser

B I Korelitz

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) is commonly treated with immunomodulators such as azathioprine and 6-mercaptopurine (6-MP). Studies examining lymphoma risk in IBD patients treated with these medications have been underpowered and have yielded conflicting conclusions. AIMS: The purpose o...

Subject

Azathioprine

Relative risk

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!